AGP Executive Report
Last update: 10 hours agoDigital Disruption: Microsoft’s global outage disrupted health services, including GPs and pharmacies, as well as business communications. The company attributed the disruption to server problems and said it had found no signs of malicious activity. Drug Manufacturing: Ghana’s National Vaccine Institute says unpredictable demand is deterring investment in local pharmaceutical production. Regional pooled purchasing could help guarantee orders and unlock financing. Radiopharma Growth: PharmaLogic agreed to buy Lantheus’ New Jersey radiopharmaceutical manufacturing business, expanding capacity for developing and producing targeted cancer treatments. Vaccine Market: Bavarian Nordic beat third-quarter revenue forecasts, citing strong travel-health sales, led by rabies vaccines and supported by its chikungunya vaccine launch. Cancer Research: Silexion Therapeutics dosed the first patient in a Phase 2/3 trial of its experimental pancreatic cancer therapy. Hospital Deal: St. Luke’s Hospital signed a letter of intent to join BJC Health; financial terms and the deal timeline have not been disclosed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.